Discovery of 7-(4-(3-ethynylphenylamino)-7-methoxyquinazolin-6-yloxy)-N-hydroxyheptanamide (CUDc-101) as a potent multi-acting HDAC, EGFR, and HER2 inhibitor for the treatment of cancer (Q43167427)
Jump to navigation
Jump to search
scientific article published in March 2010
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Discovery of 7-(4-(3-ethynylphenylamino)-7-methoxyquinazolin-6-yloxy)-N-hydroxyheptanamide (CUDc-101) as a potent multi-acting HDAC, EGFR, and HER2 inhibitor for the treatment of cancer |
scientific article published in March 2010 |
Statements
1 reference
Discovery of 7-(4-(3-ethynylphenylamino)-7-methoxyquinazolin-6-yloxy)-N-hydroxyheptanamide (CUDc-101) as a potent multi-acting HDAC, EGFR, and HER2 inhibitor for the treatment of cancer (English)
1 reference
Xiong Cai
1 reference
Hai-Xiao Zhai
1 reference
Jing Wang
1 reference
Jeffrey Forrester
1 reference
Hui Qu
1 reference
Ling Yin
1 reference
Cheng-Jung Lai
1 reference
Rudi Bao
1 reference
Changgeng Qian
1 reference
1 March 2010
1 reference
1 reference
53
1 reference
5
1 reference
2000-2009
1 reference
Identifiers
1 reference
1 reference